This Week in Nature

In Nature, a group from Massachusetts General Hospital presented details about new, high-fidelity CRISPR/Cas9 nuclease that enable targeted genome editing with no apparent off-target effects. The nuclease is designed to carry alterations that reduce non-specific DNA contacts, and when targeted to standard non-repetitive sequences, it rendered nearly all off-target events undetectable by genome-wide break capture and targeted sequencing methods.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.